These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 1455420)
21. [Analysis of therapeutic factors related to survival rate for malignant glioma patients--report from Brain Tumor Registry in Japan, Vol. 6, 1987]. Nomura K Gan No Rinsho; 1989 Sep; 35(11):1219-25. PubMed ID: 2810771 [TBL] [Abstract][Full Text] [Related]
22. Regrowth patterns of supratentorial gliomas: estimation from computed tomographic scans. Tsuboi K; Yoshii Y; Nakagawa K; Maki Y Neurosurgery; 1986 Dec; 19(6):946-51. PubMed ID: 3027609 [TBL] [Abstract][Full Text] [Related]
23. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study. Chang CH; Horton J; Schoenfeld D; Salazer O; Perez-Tamayo R; Kramer S; Weinstein A; Nelson JS; Tsukada Y Cancer; 1983 Sep; 52(6):997-1007. PubMed ID: 6349785 [TBL] [Abstract][Full Text] [Related]
24. The increasing incidence of malignant gliomas and primary central nervous system lymphoma in the elderly. Werner MH; Phuphanich S; Lyman GH Cancer; 1995 Nov; 76(9):1634-42. PubMed ID: 8635069 [TBL] [Abstract][Full Text] [Related]
25. High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers. Kosztyla R; Chan EK; Hsu F; Wilson D; Ma R; Cheung A; Zhang S; Moiseenko V; Benard F; Nichol A Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1100-6. PubMed ID: 24161427 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of malignancy in ring enhancing brain lesions on CT by thallium-201 SPECT. Källén K; Heiling M; Andersson AM; Brun A; Holtås S; Ryding E; Rosén I J Neurol Neurosurg Psychiatry; 1997 Nov; 63(5):569-74. PubMed ID: 9408094 [TBL] [Abstract][Full Text] [Related]
29. [Radiotherapy of 211 cerebral gliomas]. Larochelle M; Chabot P; Martin P; Blais R Union Med Can; 1985 Sep; 114(9):790-2. PubMed ID: 2997966 [No Abstract] [Full Text] [Related]
30. Malignant glioma grade 3 and 4: how relevant is timing of radiotherapy? Wehming FM; Wiese B; Nakamura M; Bremer M; Karstens JH; Meyer A Clin Neurol Neurosurg; 2012 Jul; 114(6):617-21. PubMed ID: 22244251 [TBL] [Abstract][Full Text] [Related]
31. Treatment results by uneven fractionated irradiation, low-dose rate telecobalt therapy as a boost, and intraoperative irradiation for malignant glioma. Yamada S; Takai Y; Nemoto K; Ogawa Y; Kakuto Y; Hoshi A; Sakamoto K; Kayama T; Yoshimoto T Tohoku J Exp Med; 1992 Aug; 167(4):259-66. PubMed ID: 1336904 [TBL] [Abstract][Full Text] [Related]
32. Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy. Mizoe JE; Tsujii H; Hasegawa A; Yanagi T; Takagi R; Kamada T; Tsuji H; Takakura K; Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):390-6. PubMed ID: 17459607 [TBL] [Abstract][Full Text] [Related]
33. Radiation necrosis or glioma recurrence: is computer-assisted stereotactic biopsy useful? Forsyth PA; Kelly PJ; Cascino TL; Scheithauer BW; Shaw EG; Dinapoli RP; Atkinson EJ J Neurosurg; 1995 Mar; 82(3):436-44. PubMed ID: 7861222 [TBL] [Abstract][Full Text] [Related]
34. [Iridium 192 brachytherapy of supra-tentorial high grade glioma recurring in irradiated areas: technique and preliminary results of the Pitié-Salpêtrière hospital group]. Boisserie G; Cornu P; Dormont D; Sahel M; Hardiman C; Tep B; Mandin AM; Barret C; Faillot T; Delattre JY; Monjour A; Poisson M; Marsault C; Philippon J; Simon JM; Baillet F; Mazeron JJ Bull Cancer Radiother; 1996; 83(3):144-52. PubMed ID: 8977564 [TBL] [Abstract][Full Text] [Related]
35. Interstitial radiogold implantation for the treatment of recurrent high-grade gliomas. Larson GL; Wilbanks JH; Dennis WS; Permenter WD; Easley JD Cancer; 1990 Jul; 66(1):27-9. PubMed ID: 2162243 [TBL] [Abstract][Full Text] [Related]
36. Prognostic value of magnetic resonance imaging-guided stereotactic biopsy in the evaluation of recurrent malignant astrocytoma compared with a lesion due to radiation effect. McGirt MJ; Bulsara KR; Cummings TJ; New KC; Little KM; Friedman HS; Friedman AH J Neurosurg; 2003 Jan; 98(1):14-20. PubMed ID: 12546347 [TBL] [Abstract][Full Text] [Related]
38. [Evaluation of ACNU alone and combined with tegafur as additions to radiotherapy of the treatment of malignant gliomas--a cooperative clinical trial]. Ushio Y; Abe H; Suzuki J; Tanaka R; Kitamura K; Miwa T; Matsutani M; Takeuchi K; Takakura K; Nomura K No To Shinkei; 1985 Oct; 37(10):999-1006. PubMed ID: 3000412 [TBL] [Abstract][Full Text] [Related]
39. Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma. Prados MD; Scott CB; Rotman M; Rubin P; Murray K; Sause W; Asbell S; Comis R; Curran W; Nelson J; Davis RL; Levin VA; Lamborn K; Phillips TL Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):653-9. PubMed ID: 9486616 [TBL] [Abstract][Full Text] [Related]
40. Necrosis as a prognostic criterion in malignant supratentorial, astrocytic gliomas. Nelson JS; Tsukada Y; Schoenfeld D; Fulling K; Lamarche J; Peress N Cancer; 1983 Aug; 52(3):550-4. PubMed ID: 6305479 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]